Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/11/2012US8329192 Campylobacter polypeptides and methods of use
12/11/2012US8329191 Three-branched polyethylene glycol-G-CSF conjugate
12/11/2012US8329185 Method for isolating and purifying grass pollen allergens
12/11/2012US8329182 Immunoglobulin chimeric monomer-dimer hybrids
12/11/2012US8329178 Antibodies against CXCR4 and methods of use thereof
12/11/2012US8329163 Attenuated gram negative bacteria
12/11/2012US8329160 Interferon alpha sequential regimen for treating cancers
12/11/2012US8329144 Diagnostic and therapeutic epitope, and transgenic plant
12/11/2012CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
12/11/2012CA2606348C Anti-il-6 antibodies, compositions, methods and uses
12/11/2012CA2538183C Chromatographic separation of therapeutic polypeptides
12/11/2012CA2513104C Survivin-derived peptides and use thereof
12/11/2012CA2481479C Novel flavivirus antigens
12/11/2012CA2395590C Method of producing human serum albumin involving heating step
12/11/2012CA2328129C Methods and compositions for expression of transgenes in plants
12/09/2012CA2779710A1 F11 receptor (f11r) antagonists as therapeutic agents
12/06/2012WO2012167251A1 Long-acting glp-1/glucagon receptor agonists
12/06/2012WO2012166964A1 Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production
12/06/2012WO2012166906A1 Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
12/06/2012WO2012166875A2 Modulating innate immune cell activity by lunasin and selected cytokines
12/06/2012WO2012166626A1 Reagents and methods for treating dental disease
12/06/2012WO2012166594A1 Peptide-crosslinked bioactive polymeric materials
12/06/2012WO2012166450A1 Genetic vaccines against hendra virus and nipah virus
12/06/2012WO2012165740A1 Composition for improving dedifferentiation of cells and method for producing inducted pluripotent stem cells using the same
12/06/2012WO2012165678A1 Oshmb4 gene derived from oryza sativa, and use thereof
12/06/2012WO2012165544A1 Protein a mutant protein having reduced affinity in acidic region, and antibody capture agent
12/06/2012WO2012165356A1 Thermosensitive polyamino acid or salt thereof
12/06/2012WO2012164849A1 Method for producing protein semiconductor
12/06/2012WO2012164321A1 Organ and tissue transplantation solution containing bmp-7
12/06/2012WO2012164137A1 Stem cells and neural crest cells derived from olfactory ensheathing glia, and uses thereof
12/06/2012WO2012164088A1 Diagnosis method of active tuberculosis
12/06/2012WO2012164004A1 Novel antigen peptide and uses thereof
12/06/2012WO2012163817A2 Immunogenic composition
12/06/2012WO2012163811A1 Immunogenic composition
12/06/2012WO2012163810A1 Immunogenic composition
12/06/2012WO2012163807A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
12/06/2012WO2012163765A1 Means and methods for diagnosing and treating multiple sclerosis
12/06/2012WO2012163533A1 T cell epitope of candida albicans
12/06/2012WO2012162856A1 Crystal of cytokine receptor
12/06/2012WO2012136506A3 Microorganism and processes for the fermentative production of an organo-chemical compound
12/06/2012WO2012120315A3 Mutant proteins and methods for producing them
12/06/2012WO2012109624A3 Monovalent and multivalent multispecific complexes and uses thereof
12/06/2012WO2011117582A9 Dendritic cell inhibitory proteins from ticks
12/06/2012US20120311741 Sophorolipid transporter protein
12/06/2012US20120309944 Growth Hormones With Prolonged In-Vivo Efficacy
12/06/2012US20120309939 Production of Therapeutic Proteins in Photosynthetic Organisms
12/06/2012US20120309936 Reducing the immunogenicity of fusion proteins
12/06/2012US20120309935 Method of reducing glycosylation of proteins, processes and proteins thereof
12/06/2012US20120309694 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs
12/06/2012US20120309692 Activation of Peptide Prodrugs by hK2
12/06/2012US20120309691 Tumor targeted delivery of immunomodulators by nanopolymers
12/06/2012US20120309689 Hatching fluid enzymes and uses thereof
12/06/2012US20120309683 USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
12/06/2012US20120309681 Treating or ameliorating some neuroendocrine disorders in male with help of prolactin
12/06/2012US20120309679 Igf-i poly (ethylene glycol) conjugates
12/06/2012US20120309091 Methods And Compositions For Gene Inactivation
12/06/2012US20120309032 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection
12/06/2012US20120309015 Methods and compositions for detecting endometrial or ovarian cancer
12/06/2012US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function
12/06/2012US20120308638 Antimicrobial peptides
12/06/2012US20120308602 Recombinant RSV Virus Expression Systems And Vaccines
12/06/2012US20120308599 Vaccine and methods of use against strongyloides stercoralis infection
12/06/2012US20120308596 Novel streptococcus antigens
12/06/2012US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012US20120308537 Use Of Collagen Type VII For Maintaining And Re-Inducing Osteogenic Abilities Of Mesenchymal Stem Cells
12/06/2012US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
12/06/2012US20120308482 Monkey Homolog of Human Interferon Omega
12/06/2012US20120308481 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
12/06/2012CA2837710A1 Long-acting glp-1/glucagon receptor agonists
12/06/2012CA2837582A1 Genetic vaccines against hendra virus and nipah virus
12/06/2012CA2837518A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
12/06/2012CA2837515A1 Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/06/2012CA2837412A1 Dispersion and detachment of cell aggregates
12/06/2012CA2837395A1 Immunogenic composition
12/06/2012CA2837393A1 Immunogenic composition
12/06/2012CA2837087A1 Peptide crosslinked bioactive polymeric materials
12/06/2012CA2832391A1 Means and methods for diagnosing and treating multiple sclerosis
12/05/2012EP2530161A2 Process for producing poxviruses and poxvirus compositions
12/05/2012EP2530158A1 Genes encoding proteins able to enhance heat resistance of plants and microorganism and uses thereof
12/05/2012EP2530147A2 Influenza hemagglutinin and neuraminidase variants
12/05/2012EP2530088A1 Means and methods for diagnosing and treating multiple sclerosis
12/05/2012EP2530087A2 Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
12/05/2012EP2529619A2 Treating neurological disorders
12/05/2012EP2529227A1 Cytomegalovirus-based immunogenic preparations
12/05/2012EP2529017A2 Methods and compositions for targeted polynucleotide modification
12/05/2012EP2529006A2 Methods&compositions for improving protein production
12/05/2012EP2528943A1 Factor vii fusion polypeptides
12/05/2012EP2528942A1 Novel compounds and their effects on feeding behaviour
12/05/2012EP2528941A2 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
12/05/2012EP2528940A1 Methods of intracellular conversion of single-chain proteins into their di-chain form
12/05/2012EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
12/05/2012EP2528933A1 Process for the purification of glycoproteins
12/05/2012EP2528931A2 Cyclovirus and method of use
12/05/2012CN1437479B Recombinant intracellular pathogen vaccines and methods for use
12/05/2012CN102812121A Methods & compositions for improving protein production
12/05/2012CN102812039A Conjugated proteins
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 2916